KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

SNO August Brain Mets Conf, page-3

  1. harvett
    6,849 Posts.
    lightbulb Created with Sketch. 2536
    clock Created with Sketch.
    03/08/19
    10:51
    Post #: 39842755
    Secondary Outcome Measures :
    1. CBR [ Time Frame: 18 and 24 weeks ]
      rate of patients with clinical benefit at 18 and 24 weeks
    2. https://clinicaltrials.gov/ct2/show/NCT03765983
    Maybe considering the trial started dec 2018 and first enrolment Feb 2019. Aug would spot on for 18 week or even 24 week metrics.
    Watch this spot for sure as it was highlighted in the Kazia June newsletters of coming dates
    KZA Price at posting: 38.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 8  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
UNT UNITH hard launching AI 'digital human' platform too 600+ companies as AI thematic survives sell-off
right-arrow Created with Sketch.
NEWS Good habits matters when it comes to finances
right-arrow Created with Sketch.
MBK Metal Bank setting up shop in Saudi Arabia as part of MENA expansion plans
right-arrow Created with Sketch.
SUM Summit Minerals jumps 6% as LiDAR survey boosts confidence in niobium mineralisation
right-arrow Created with Sketch.
NEWS Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.